A comprehensive review of the therapeutic potential of curcumin nanoformulations. (15th June 2021)

• Record Type: Journal Article
• Authors: Khezri, Khadijeh; Saeedi, Majid; Mohammadamini, Hassan; Zakaryaei, Abbas Seyed
• Is Part Of: Phytotherapy research. Volume 35:Number 10(2021)
• Page Start: 5527
• Page End: 5563
• Publication Date: 2021-06-15
• Subjects: bioavailability -- biological applications -- commercial nanoproducts -- Curcumin -- nanoformulations -- therapeutic mechanisms; Materia medica, Vegetable -- Periodicals; Botany, Medical -- Periodicals; Medicinal plants -- Periodicals; Plant Extracts -- therapeutic use -- Periodicals; Plants, Medicinal -- Periodicals; 581.634
• DOI: 10.1002/ptr.7190
• Languages: English
• ISSNs: 0951-418X

Abstract

Abstract: Today, due to the prevalence of various diseases such as the novel coronavirus (SARS‐CoV‐2), diabetes, central nervous system diseases, cancer, cardiovascular disorders, and so on, extensive studies have been conducted on therapeutic properties of natural and synthetic agents. A literature review on herbal medicine and commercial products in the global market showed that curcumin (Cur) has many therapeutic benefits compared to other natural ingredients. Despite the unique properties of Cur, its use in clinical trials is very limited. The poor biopharmaceutical properties of Cur such as short half‐life in plasma, low bioavailability, poor absorption, rapid metabolism, very low solubility (at acidic and physiological pH), and the chemical instability in body fluids are major concerns associated with the clinical applications of Cur. Recently, nanoformulations are emerging as approaches to develop and improve the therapeutic efficacy of various drugs. Many studies have shown that Cur nanoformulations have tremendous therapeutic potential against various diseases such as SARS‐CoV‐2, cancer, inflammatory, osteoporosis, and so on. These nanoformulations can inhibit many diseases through several cellular and molecular mechanisms. However, successful long‐term clinical results are required to confirm their safety and clinical efficacy. The present review aims to update and explain the therapeutic potential of Cur nanoformulations.